Search

Long non-coding (lnc) RNAs play crucial functions in human cancer. However, until recently, the involvement of the lncRNA GAS6-AS1 in breast cancer (BCa) malignancy has not been studied exhaustively. The roles and underlying mode of action of GAS6-AS1 action in BCa progression were examined through functional experiments. A decline in GAS6-AS1 level led to a significant decrease in BCa cell proliferation, and the ability for colony formation. Here, GAS6-AS1 competed as endogenous RNA by sequestering microRNA-215-5p (miR-215-5p) causing an enhanced expression of SRY-box transcription factor 9 (SOX9). The effects of silencing GAS6-AS1 on BCa malignant phenotypes could be ameliorated by inhibiting miR-215-5p or restoring SOX9. Thus, GAS6-AS1 acted as a lncRNA that drives tumor in BCa, and enabled progression of BCa through miR-215-5p /SOX9 axis regulation. These outcomes show that the GAS6-AS1/miR-215-5p/SOX9 axis is a potentially effective target for cancer treatment and management. [ABSTRACT FROM AUTHOR]

Objective: To test the effects of two kinds of diaryliodonium on the degree of conversion (DC), the compressive strength (CS) and the cure depth (CD) of the light-curing composite resin., Methods: BisS-GMA was used as reisin matrix, with TEGDMA as diluent and SiO2 as inorganic filler. CQ, DMAEMA and two different kinds of diaryliodonium (diphenyliodonium hexafluorophosphate and bis (p-tolyl) iodonium hexafluorophosphate) were used as photoinitiator, respectively. The DC, CS, CD were measured and compared by the FTIR spectroscopy, and the tensile strength of machine et al., Results: Diaryliodonium led to greater DC, CS, and CD of the light-curing composite resin. The DC, CS, and CD of the light-curing composite resin increased more with bis (p-tolyl) iodonium hexafluorophosphate than with diphenyliodonium hexafluorophosphate., Conclusion: Diaryliodonium can improve the DC, CS, and CD properties of light-curing composite resin. Bis (p-tolyl) iodonium hexafluorophosphate has better performance than diphenyliodonium hexafluorophosphate in improving photosensibility and solubility of the photoinitiator system.